NCS Multistage Holdings, Inc. (NCSM) Earnings Call Transcript & Summary
March 5, 2026
Earnings Call Speaker Segments
Corbin Woodhull
executiveVictor, thanks. I'd like to extend a warm welcome to everybody joining this conference call, and I want to express appreciation to NCS Multistage's management team for making today's call possible. Joining us are Mr. Ryan Hummer, who serves as CEO of NCS Multistage, along with Mr. Mike Morrison, our CFO. Listeners should be aware that certain remarks made today contain forward-looking statements, including our financial guidance and commentary about anticipated future financial results and business operations. A number of risks and uncertainties surround these statements, and they could lead to actual outcomes differing materially from any expectations otherwise described here. We encourage you to review our most recent annual report on Form 10-K as well as our latest SEC filings, where risk factors and cautions about forward-looking statements are detailed. The remarks we make today, together with the operating results contained in our earnings release, include these non-GAAP financial measures: EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA less share-based compensation, adjusted gross profit, adjusted gross margin, free cash flow, free cash flow less distributions to noncontrolling interest, net working capital, return on invested capital, net operating profit after tax and average invested capital. Reconciliations of these non-GAAP measures to the most comparable GAAP financial measures, along with the measures themselves, appear in our fourth quarter earnings release, available on our website at ncsmultistage.com. At this point I'll hand things over to Ryan Hummer.
Ryan Hummer
executiveAppreciate that, Corbin. Welcome to all the investors, analysts, and employees who are with us today as we discuss what we delivered in the fourth quarter and across the entirety of 2025. My plan is to begin with a review of where we landed financially over the past year, and after that we'll walk through several commercial and operational wins from 2025 and the early part of 2026 — achievements that align with both NCS' vision and the strategies at the heart of our business. I'll also address how the ResMetrics integration is going, and then set out the strategic goals we're pursuing this year. Once I'm finished, Mike will walk everyone through the quarter's numbers and the guidance we're giving for the near term. For NCS, 2025 stood out as an extremely important year, and a very successful one. We closed the year on a high note with a fourth quarter that outperformed, and for both that quarter and the entire year we finished ahead of the upper bound of our guidance across revenue, adjusted EBITDA and free cash flow. Comparing to the prior year, revenue increased 13% versus 2024, or 10% when you exclude what ResMetrics contributed — that's the business we bought at the end of July 2025. Growth in revenue came through in the U.S., Canada and international markets, all three, even with the tough conditions in the industry. Adjusted EBITDA was up 20% from a year earlier, expanding more quickly than revenue and reaching $26.7 million, which works out to an adjusted EBITDA margin of 15%. When we account for what was paid out to noncontrolling interest, free cash flow landed at $18.9 million — a figure representing over 70% conversion from adjusted EBITDA to free cash flow, which really highlights what our asset-light approach delivers. On top of reinforcing the balance sheet, we also closed the strategic purchase of ResMetrics, which deepens our standing worldwide in tracer diagnostics. ResMetrics fits our business extremely well as a complementary piece, and I'll get into that shortly. Let me begin with our strategy. At NCS, we aim to push energy development toward greater efficiency, intelligence, and sustainability by making well performance that no one else can match possible. Operationally, we bring that aim to life by going after the roughly $10 billion worldwide completions market, using an integrated set of products and services built so our customers can consistently get the most value out of their unconventional assets. Our products reach many different kinds of markets. In North America, those are the more established ones. In Argentina and the Middle East, they're the emerging, fast-growing unconventional plays. And in places that follow more traditional approaches, such as the North Sea and Alaska, we're putting unconventional technology and methods to work effectively. We work alongside our customers there to create fresh market opportunities for what we sell and do in environments that are technically tough. That covers creative answers for heavy oil through steam-assisted gravity drainage, known as SAGD, as well as for deepwater offshore operations and for enhanced geothermal systems. On top of that, we keep teaming up with our customers to drive greater uptake of our offerings while a well is in its production stage. Like we've mentioned previously, our company relies on three main strategies, and two guiding principles back them up. I'll go through all of them, sharing recent developments to show how we're building value for stakeholders over the long haul. The first of these strategies is about growing the top positions we already occupy in the marketplace. This includes the share we hold and the connections we've built in Canada, our extensive global experience with fracturing systems, and our expertise in tracer diagnostics, which got a boost from the ResMetrics merger. This approach shows up when we partner with clients to introduce what we offer into additional areas, often leveraging both our substantial history and the bonds formed with those clients over time. One illustration would be the debut application of our fracturing systems technology for stimulation on a SAGD project up in Canada during 2025, which additionally made use of our tracer diagnostic services to confirm production outcomes. A further illustration involves the first anticipated deployment of our Ratek Proppex sliding sleeve system featuring integrated screen technology, which we plan to hand over to our customer later in this year for deployment in the deepwater Gulf of America. A secondary core strategy is to seize high-margin growth chances across the globe. Over the years, I've often highlighted how our customer base in the North Sea has continued to expand. Already this year, we've secured orders from two new customers, and both of them operate in the Dutch portion of the North Sea. In 2025, we completed our first well in the Middle East, where we deployed our fracturing systems technology, and we expect more applications for it in that market in 2026. On top of that, we recorded our first sales of repeat precision frac plugs in the Middle East during 2025, and sales to two customers in that region are still ongoing and will continue through 2026. The final piece of our core strategy is delivering innovative solutions to the market that address complex customer challenges. This turned out to be a productive and thrilling year for us, with a number of notable accomplishments; up in Canada, we just recently set up our first Terrus AICV system, which incorporates an integrated autonomous inflow control valve to enhance the production profile of wells that are more mature, cutting produced water volumes while permitting possible gains in oil rates; we anticipate further installations of this system throughout 2026. At Repeat Precision, adoption of StageSaver by customers has played a real part in driving growth. New clients came aboard across 2025 and into early 2026. That demonstrates how much customers value the contingency mitigation this offering delivers, alongside the proven results from our PurpleSeal frac plugs. We're also capitalizing on money we've put into fresh tracer diagnostic offerings — including rapid trace, our on-site tracer detection product, our Lume8 multi-day composite samplers, and wider rollout of ResMetrics SmartProp particulate tracer across Canada and other regions. Next, let me turn to the 2 guiding principles underpinning our long-term strategy. First, we seek to maximize financial flexibility. This is where our business model really shows what it's made of. We closed the year with net cash of about $29 million, plus a revolver we hadn't drawn on. Free cash flow for 2025 landed at approximately $22 million. After distributions to our noncontrolling interest, $19 million of that remained as free cash flow. That works out to over 70% of adjusted EBITDA for the year — a meaningful conversion rate, especially once you consider that revenue grew 13% compared with the prior year. Our second guiding principle is keeping the promise. That promise captures what we commit to as a company — to employees, customers, vendors, and other stakeholders — around how we conduct business, and our company values are woven into it. It also says something about the areas we prioritize: technology, quality, health, safety, and the environment. Now, a brief update on the ResMetrics integration. That deal provided an instant lift to our tracer diagnostics platform, broadened our reach into new Middle Eastern markets, and aligned nicely with both NCS' culture and our capital-light way of doing business. I'm glad to share that in the U.S. we now go to market under the ResMetrics commercial brand, and our sales and business development team has been brought together. On top of that, we've enhanced our laboratory information management systems to build in certain ResMetrics processes, which allows us to plan and carry out customer jobs consistently. Combining our operations and our manufacturing will take place soon afterward, and by the middle of the year both manufacturing and our U.S. lab operations are slated to be consolidated in Tulsa. The cost savings we pinpointed when doing this deal are within clear reach, and we're moving forward on chances to benefit from revenue synergies — something we framed from the start as potential upside stemming from putting the two companies together. To close out this part, I'll review what we're targeting this year, which is straightforward and in line with our strategy over the long haul. During 2026, we intend to expand revenue more quickly than the market's underlying activity, in the U.S. as well as abroad, aiming to increase overall revenue relative to 2025, counting a full twelve months of what ResMetrics adds. Our goal is for more than half of our adjusted EBITDA to be converted into free cash flow. We plan to accelerate commercial uptake of the technology we've recently rolled out and newly introduced, generate further commercial wins for what we sell and service, and continue making inroads into the most recently entered markets. Efforts are ongoing to steadily strengthen how engaged our employees are and to keep workplaces safe. Beyond that, we intend to carry forward programs already in motion: taking part in markets involving higher temperatures and production, enabling stronger decisions grounded in data, and growing gross margin via strategic steps that create efficiencies while refining both the cost and the performance of the products and services we offer. Mike will now walk you through more detail on our fourth quarter 2025 results and our first quarter 2026 guidance.
Mike Morrison
executiveThanks, Ryan. Yesterday's earnings release showed Q4 revenue of $50.6 million — up 13% versus Q4 last year and well past the top end of the guidance range we gave. The quarter's growth came from solid double-digit percentage gains in product revenue and services revenue alike. Geographically, the U.S. posted the strongest result, rising 69% year over year, while international added 5% and Canada fell 7%. What drove the U.S. improvement was better sales of the NCS fracturing system, more plug revenue out of Repeat Precision, and a $2.9 million contribution from ResMetrics, which we bought on July 31, 2025. Canada's quarterly decrease came from somewhat softer activity levels tied to a broad market headwind. Q4 revenue was our largest of the year and rose 9% sequentially, lifted by gains in Canada and the U.S. that were partly offset by a drop internationally. Adjusted gross profit — total revenues minus total cost of sales, excluding depreciation and amortization expense — came to $21.2 million in Q4, an adjusted gross margin of 42%, versus 43% in the same period of 2024. Even with the helpful ResMetrics contribution, that modest margin decline stemmed from the mix of international tracer diagnostic jobs and fracturing system service activity, partly offset by better gross margin on product sales. SG&A costs totaled $14.2 million in Q4, 5% below the same period a year earlier, reflecting the timing of incentive bonus accruals booked in last year's fourth quarter, along with reduced professional fees and lower share-based compensation expense tied to our cash settled awards, which we expense as our stock price moves. ResMetrics added $600,000 to SG&A during the quarter. The provision for litigation, net of recoveries, was a $900,000 benefit, stemming from an October 2025 ruling by the Federal Court of Appeal of Canada that sent a prior judgment against NCS in a patent dispute back to the trial court and cut the cost award. As a result, $900,000 of that cost award went back to NCS in November 2025. Other income of $1.1 million was down from $2.4 million in Q4 of 2024, mainly because of the timing of royalty income from licenses tied to our intellectual property, with 2025 activity matching the roughly $1 million per quarter we consider normalized. Q4 net income reached $15.0 million, or $5.34 in diluted earnings per share, including a $9.8 million positive impact from releasing our deferred tax valuation allowance. That reversal reflects confidence in our ongoing profitability and in our capacity to fully use our deferred tax assets going forward. Our adjusted EBITDA came in at $9.2 million, translating to a margin above 18%. That tops the upper bound of the guidance range we gave for the quarter, and it's also higher than the $8.2 million recorded in last year's fourth quarter. Now let's move on to how we performed across all of 2025. Revenue reached $183.6 million, which is a gain of more than $21 million, or 13%, versus 2024, and that beat the 5% midpoint from the initial full-year guidance range we provided. If you set aside the revenue that ResMetrics brought in — $5.2 million across the 5 months after the acquisition closed, a figure that came in a bit ahead of what we anticipated — then revenue rose 10% for the year. Every region posted higher total revenue for the year. Our adjusted gross margin for fiscal 2025 held steady at 41%, down only about 40 basis points from the prior year. SG&A expense for 2025 came to $58.8 million, which is $1.0 million more than last year. ResMetrics added $1.1 million of SG&A during 2025, and greater share-based compensation expense also pushed SG&A higher. That said, these SG&A increases were partly offset by reduced professional service fees, lower R&D expenses, and other SG&A reductions. Other income fell to $4.8 million, down from $7.3 million in 2024, mainly because of when royalty income gets recognized, as we've discussed before. On top of that, the earlier year got a boost from a technical service agreement with our local partner in Oman, which wrapped up in November 2024. Net income for 2025 rose to $23.7 million, or $8.65 in diluted earnings per share, and that figure includes a net positive impact of $11.5 million tied to releasing our U.S. and Canadian deferred tax valuation allowances, as we discussed earlier. Last year, net income stood at $6.6 million, or $2.55 in diluted earnings per share. Adjusted EBITDA reached $26.7 million, a 20% rise from $22.3 million in 2024, while the adjusted EBITDA margin widened to 14.5% from 13.7%. Let's shift to the balance sheet. As of December 31, cash stood at $36.7 million with total debt of $7.6 million — all of it finance lease obligations — leaving us with a net positive cash position of $29.1 million. Borrowing base availability under our undrawn ABL facility came to $24.4 million, which puts total liquidity at roughly $61 million. Now I'll cover a few guidance items for the first quarter of 2026. We're currently projecting total revenue for the first quarter somewhere between $49 million and $53 million, which works out to a 2% increase at the midpoint over the first quarter of 2025. U.S. revenue should land between $19.5 million and $20.5 million, international revenue between $3 million and $4 million, and Canadian revenue between $26.5 million and $28.5 million. Adjusted gross margin should come in somewhere between 39% and 41%, a slight step down from the first quarter of 2025. Adjusted EBITDA should fall between $6.5 million and $8.5 million, and depreciation and amortization expense for the first quarter should be about $1.6 million. Having said that, I'll now turn things over to Ryan, and he'll give our complete 2026 full-year guidance along with some closing comments.
Ryan Hummer
executiveThanks, Mike. As we look toward 2026, we're expecting the market to remain difficult. Based on what we can see right now, total customer activity across North America looks like it will be flat to down in the coming year compared with 2025, while things ought to improve in the key international markets we operate in — though those improvements will likely be concentrated in the back half, especially in the Middle East. With all that in mind, here's what we're guiding to for the full year 2026. Right now, we expect revenue for the full year to fall between $184 million and $194 million, and adjusted EBITDA for the full year to come in somewhere in the range of $26 million to $29 million. Revenue growth ought to be driven primarily by the U.S. and our international markets, where our positioning allows us to outperform the underlying trends through continued share gains — notably at Repeat Precision — along with adoption of new products and further international expansion. In Canada, we're currently expecting revenue to be down year-over-year, because we're facing headwinds from a reduced total rig count, especially in Q1, plus certain customer consolidation that will likely push pro forma activity levels lower. Our guidance doesn't incorporate any significant additional impact from the trade landscape as it stands now, which is still volatile — including the possibility of new or retaliatory tariffs involving the U.S., Canada and Mexico. It also doesn't reflect what the continuing conflict in the Middle East could bring, whether to operations in the region or via a sustained increase in commodity prices; for 2026, we're expecting gross capital expenditures between $1.5 million and $2 million. Beyond that, in January of 2026, we paid $1.25 million of contingent consideration related to the ResMetrics acquisition, which will appear in cash flow from investing activities. We expect free cash flow of $12 million to $16 million after distributions to our JV partner, which further bolsters our already strong balance sheet and positions us to pursue strategic investment opportunities. As of yesterday, the midpoint of our 2026 free cash flow guidance would work out to a free cash flow yield of roughly 132% relative to our market capitalization. Given the seasonal pattern of our business and consistent with prior years, we'd anticipate that achieving our annual adjusted EBITDA guidance range will be weighted toward the second half, with free cash flow weighted toward the end of the year. Before we get to Q&A, I'll close with a few comments. I'm very proud of what the NCS team accomplished in 2025; we grew revenue, adjusted EBITDA and free cash flow in a challenging market, delivering the benefits we expected as we executed our strategic plan; and we now have the infrastructure in place to support revenue growth. Going forward, we'd expect our incremental adjusted EBITDA margins to land in the 25% to 35% range. We're seeing the rewards from successfully launching new solutions that meet our customers' needs, which expands our portfolio and enlarges our addressable market. At this point, we operate as a single, unified tracer diagnostics business alongside ResMetrics. The work required to secure most of the synergies we foresaw from this combination has been completed, and further gains ought to come as we merge our U.S. lab and manufacturing activities and direct greater focus toward chances that generate revenue synergy. Our balance sheet and liquidity stay strong, with total liquidity — including amounts accessible under our revolver — above $61 million. We convert adjusted EBITDA into free cash flow effectively, as free cash flow after distributions to noncontrolling interest totaled $19 million in 2025, which equals over 70% of adjusted EBITDA. During 2026, we expect free cash flow after distributions to noncontrolling interest to again exceed 50% of adjusted EBITDA. As of yesterday, the midpoint of our 2026 free cash flow guidance would work out to a free cash flow yield of about 13% against our market capitalization. We also released our updated investor presentation yesterday, and it covers a number of items I mentioned earlier during this call. Among them are our effort to open new addressable markets, the progress we are achieving in the priority areas of our corporate strategy, and the actions we are taking across our product lines to improve profitability. We included a new slide too, one that highlights our return on invested capital, demonstrating how significantly the business has strengthened over the past several years. Although we remain focused on core metrics like revenue and EBITDA growth, margin improvement and free cash flow, it bears remembering that we vie for investment capital with our industry peers and with the broader market as well. Return on invested capital serves as an indicator of whether a company can create shareholder value over the long term. The advancement we have made fills me with pride — after-tax returns surpassing 11% in 2025 — and it reflects our disciplined capital allocation as well as the operating leverage inherent in our business as it grows. Going forward, we intend to continue raising those returns, with a medium-term goal of 15%, which we regard as highly competitive regardless of industry. With that, we are glad to take questions from the audience.
Dave Storms
analystI'd like to begin by discussing the pluses and minuses regarding the guidance. I'm aware that for two consecutive quarters now, you've signaled that a significant portion of this year's revenues will be concentrated in the latter half. Could some of that potentially be pulled forward? Or is much of the Middle East work, perhaps, still undergoing qualification, effectively fixed for Q3 and Q4?
Ryan Hummer
executiveYes, Dave, I believe that pattern will persist, correct? A portion of this relates simply to how our business fluctuates seasonally and our heavy exposure to the Canadian market, where Q1 tends to be fairly robust, followed by spring breakup during the second quarter, and then activity returns to more typical levels in the latter half. Definitely, picking up ResMetrics, which has a stronger U.S. and international emphasis, will assist in offsetting that somewhat, along with certain market share improvements we've achieved with frac plugs in Canada, which usually stay active throughout the entire year. However, I expect that seasonal trend will remain; and I think when we examine particular opportunities for NCS that aren't merely driven by the market. We're seeing numerous projects for 2026 taking shape in a way that suggests the same pattern will emerge, with most of the earnings and cash flow arriving during the latter portion of the year.
Dave Storms
analystUnderstood. That's quite useful. Now, I remember you spent some time in your prepared comments talking about specific cross-selling initiatives you've been able to pull off, especially in Canada. Is it too early to talk about any cross-selling possibilities in the Middle East tied to the ResMetrics transaction? Or should we wait until later in the year to address that?
Ryan Hummer
executiveYes. When it comes to ResMetrics internationally, we've started seeing some benefits, though they're largely within North America. As an example, I mentioned a product, a particular particulate tracer from ResMetrics called SmartProp, which was developed and initially deployed with their customers in the U.S. And we've since introduced that and used it with several clients in Canada who truly appreciate that technology; we're seeing — what I'd call, when we look at global markets, we're really looking at how some of the newer technologies we have come together within that tracer diagnostics platform. One that's particularly promising overseas is called rapid trace, which is an on-site tracer detection solution for us. And that really provides value in remote markets where collecting a sample and shipping it to a lab and waiting that stretch to receive results could be challenging, but also where the decision you make after seeing that tracer result can allow a customer to remove an asset from location and save a substantial amount of money. So that's one of the things I think will help us across many international markets. The global operations ResMetrics handles are actually covered by long-term agreements. We noted they have projects in the Emirates and in Kuwait; so, given that those agreements cover multiple years, we can certainly work to expand scope. We can also work to bring in some of the best practices we identify throughout the company. But as for revenue cross-selling, building that outside North America will take a bit more work. Additionally, for 2026, we expect gross capital expenditures to land somewhere between $1.5 million and $2.0 million.
Dave Storms
analystThanks for that. I also wanted to touch on what you're observing up in the North Sea. From what I understand, it's usually quite case-by-case. Any fresh news on that pipeline as you keep growing deepwater along with certain other distinctive capabilities?
Ryan Hummer
executiveSure. Thanks, Dave. Clearly, the North Sea has proven a tremendous win for us across the past several years, particularly when it comes to our fracturing systems technology. As I recall, during 2025 we engaged with — I think the figure was 7 customers throughout the North Sea, whether that meant sleeves sold or completion jobs carried out aboard the platforms. Earlier in my remarks I noted that we hold orders allowing us to bring 2 additional customers onto that list, and those operators are active in the Dutch portion of the North Sea. That means we currently serve clients, correct, in Norway, the U.K., and the Netherlands. So yes, the sheer reach of the client roster we've built up really reflects the product-market fit we've achieved in that area, along with the outcomes customers get from deploying that technology. I think on the previous call, we may have brought up a workshop hosted in Norway, where we saw strong customer involvement and responses from operators active not only in Norway but throughout the whole region; so our confidence in the work we're doing in the North Sea is very, very high; so regarding how that could evolve and carry forward, and how we bring that technology into additional markets. One of the customers we have in the North Sea serves as a project partner on the deepwater Gulf of America well that we anticipate taking part in later this year; so there's some linkage between them. We also have a North Sea customer with whom we're discussing further project possibilities in shallow water markets beyond the North Sea; so my expectation is that this keeps developing across the coming year or 2, though we're definitely aiming to extend that success into shallow water offshore markets, carrying it past the North Sea and then utilizing and advancing into mid and deeper waters eventually as well with our technology.
Dave Storms
analystCould I just squeeze in one more question about that? You brought up the drilling you expect to happen later this year in the Gulf of America; that's sort of a fresh market opening for you. In the medium to long term, how would you describe some of the other new market openings you might pursue?
Ryan Hummer
executiveYeah. Thanks for asking, Dave. I believe one thing that came across in the prepared remarks is the effort we've put in to create new addressable markets for our technology. The deepwater is definitely one of them, and reaching it takes a lengthy sales cycle along with a lengthy product development cycle. So we're quite encouraged about the prospect of deploying that technology for the first time, we hope, this year; and we think that will unlock further opportunities with that customer, plus opportunities with other customers who are going after the same kind of reserves down the road. Other spaces where we have development initiatives going, one is higher temperature more generally. That factors into certain deepwater markets offshore in conventional oil and gas. It also factors into the thermal oil projects in Canada. I brought up SAGD, and it also factors into enhanced geothermal systems, where customers want to take advantage of technology the oil and gas industry developed, horizontal drilling, hydraulic fracturing, to reach heat in situ deep underground and deliver baseload power that can be used to power data centers and other things; so I'd say the SAGD, or heavy oil market in Canada, is one where we believe opportunities will open up for us over the medium term. Geothermal is another, I'd say. All of those are still fairly early days. Scaling them will take time, but they're good illustrations of what we're trying to do to take part in those markets. Another one is that, in the past, we concentrated mainly on helping our customers through their completions. And inside our fracturing systems portfolio, we have an enhanced recovery suite of technology. In the past, that centered on what we'd call injection control, so helping customers be more precise in how they inject fluid, usually water, but in a waterflood or secondary recovery regime, when they do that with a horizontal injector, so they can compartmentalize the well to produce efficient sweeps and maximize the value of those waterfloods. We have a development in progress, called Terrus AICV. I brought that up earlier, and it's more of a production control solution, which ought to help our customers lower the water cut they're experiencing in their wells, and dealing with produced water is a cost for our customers. Thus, once the solution is deployed, we can assist them in lowering production operating costs; moreover, by producing preferentially via the specialized valve—favoring oil over water—an increase in oil output might also be observed. So if we can aid our clients in both enhancing their revenue profile and trimming their cost profile on current assets, we believe that will find strong application among our customers across the industry over time. And then, to return to one of your earlier questions regarding the ResMetrics integration and how it contributes to this enhanced recovery and production area. In the past, our capacity to pursue tracer deployment in waterflood projects had been somewhat constrained; however, thanks to certain new laboratory and chemical deployment methods that we have been able to employ from what ResMetrics provided; new possibilities have opened up for us within the production space on the waterflood; and our Canadian team, specifically, has enjoyed considerable success this year by going out and taking part in projects where we likely were not as competitive previously lacking those capabilities.
Ryan Hummer
executiveVictor, thanks. Our management team and Board want to extend our gratitude to all of you joining the call today — our shareholders, the analysts, and in particular our employees. The depth and breadth of expertise among our people at NCS, at Repeat Precision, and those who have come to us from ResMetrics is something I genuinely value, along with the passion and effort they put into their work. Excellent service to our customers continues to be delivered by our team, as we commercialize new products and services that will help our customers achieve greater success. We are embracing demanding, technically challenging work and producing results. We appreciate the interest everyone has shown in NCS Multistage, and we look forward to speaking again on our next quarterly earnings call.
Operator
operatorWe appreciate all of you joining us on today's call. That brings the program to an end. You're welcome to leave the line now. Wishing each of you a wonderful day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete NCS Multistage Holdings, Inc. transcript — plus 131,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to NCS Multistage Holdings, Inc. earnings transcripts and 131,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in NCS Multistage Holdings, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.